Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors

NCT07374692 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT07374692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07374692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
February 4, 2026
Completion date
September 10, 2026
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, gliomas, idh-mutant gliomas, idh-wildtype gliomas, rare cns tumor, recurrent cns tumors